Author:
Gugalavath Shailender,Pandit Deepali,Pandit Khushali,Nisar Albeena,Narula Gaurav,Bhukya Prudhvi Lal
Publisher
Springer Nature Singapore
Reference58 articles.
1. Adil MT, Rahman R, Whitelaw D, Jain V, Al-Taan O, Rashid F, Munasinghe A, Jambulingam P (2021) SARS-CoV-2 and the pandemic of COVID-19. Postgrad Med J 97(1144):110–116
2. Anthony-Gonda K, Bardhi A, Ray A, Flerin N, Li M, Chen W, Ochsenbauer C et al (2019) Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model. Sci Transl Med 11(504):aav5685. https://doi.org/10.1126/scitranslmed.aav5685
3. Bishop MR, Maziarz RT, Waller EK, Jäger U, Westin JR, McGuirk JP, Fleury I et al (2019) Tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma patients without measurable disease at infusion. Blood Adv 3(14):2230–2236
4. Bohne F, Chmielewski M, Ebert G, Wiegmann K, Kürschner T, Schulze A, Urban S, Krönke M, Abken H, Protzer U (2008) T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes. Gastroenterology 134(1):239–247
5. Català L, Orcau A, de Olalla PG, Millet J-P, Rodríguez-Mondragón A, Caylà JA, TB-HIV Working Group (2011) Survival of a large cohort of HIV-infected tuberculosis patients in the era of highly active antiretroviral treatment. Int J Tuberculosis Lung Dis 15(2):263–69, i